These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1388247)

  • 1. Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain.
    Oishi R; Itoh Y; Saeki K
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):495-9. PubMed ID: 1388247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
    Claustre Y; Benavides J; Scatton B
    J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat.
    Ahlenius S; Hillegaart V; Wijkström A
    J Pharm Pharmacol; 1990 Apr; 42(4):285-8. PubMed ID: 1974300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
    Dursun SM; Handley SL
    Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD; Wright RN; Margraf RR; Eison AS
    Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G; Barzizza A; Folghera S; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.
    Hjorth S; Magnusson T
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):463-71. PubMed ID: 2469021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.